ABO antibody titer monitoring for incompatible renal transplantation

Transfusion

Volumn 51, Issue 3, 2011, Pages 454-457

  Tobian, Aaron A R ^a   Shirey, R Sue ^a   King, Karen E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY TITER; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BONE MARROW TRANSPLANTATION; EDITORIAL; ERYTHROCYTE; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION;

EID: 79952462236     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03049.x     Document Type: Editorial

References (36)

1. Szulman AE. The histological distribution of blood group substances A and B in man. J Exp Med 1960;111:785-800.
2. Hogman C. The principle of mixed agglutination applied to tissue culture systems; a method for study of cell-bound blood-group antigens. Vox Sang 1959;4:12-20.
3. Breimer ME, Molne J, Norden G, Rydberg L, Thiel G, Svalander CT. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006;82:479-85.
4. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007;18:1046-56. (Pubitemid 46536891)
5. Montgomery RA, Hardy MA, Jordan SC, Racusen LC, Ratner LE, Tyan DB, Zachary AA. Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation 2004;78:181-5.
6. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002;13:2371-80. (Pubitemid 34925248)
7. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, Nankivell BJ. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007;7:2757-68. (Pubitemid 350045771)
8. U.S. Department of Health and Human Services 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Rockville (MD): U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2009.
9. Gentry SE, Segev DL, Montgomery RA. A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant 2005;5:1914-21. (Pubitemid 41039865)
10. Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005;293:1883-90. (Pubitemid 40548185)
11. Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion 2009;49:1248-54.
12. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009;87:1246-55.
13. Toma H, Tanabe K, Tokumoto T. Long-term outcome of ABO-incompatible renal transplantation. Urol Clin North Am 2001;28:769-80. (Pubitemid 34028040)
14. Genberg H, Kumlien G, Wennberg L, Tyden G. Isoagglutinin adsorption in ABO-incompatible transplantation. Transfus Apher Sci 2010;43:231-5.
15. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
16. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008;48:2453-60.
17. Winters JL, Gloor JM, Pineda AA, Stegall MD, Moore SB. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 2004;19:79-85. (Pubitemid 39006612)
18. Sivakumaran P, Vo AA, Villicana R, Peng A, Jordan SC, Pepkowitz SH, Klapper EB. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts. J Clin Apher 2009;24:155-60.
19. Ishida H, Koyama I, Sawada T, Utsumi K, Murakami T, Sannomiya A, Tsuji K, Yoshimura N, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S, Takahashi K, Teraoka S, Ito K, Toma H, Agishi T. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000;70:681-5. (Pubitemid 30659655)
20. Toki D, Ishida H, Setoguchi K, Shimizu T, Omoto K, Shirakawa H, Iida S, Horita S, Furusawa M, Ishizuka T, Yamaguchi Y, Tanabe K. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009;9:567-77.
21. Tobian AA, Shirey RS, Montgomery RA, Cai W, Haas M, Ness PM, King KE. ABO antibody titer and risk of antibodymediated rejection in ABO-incompatible renal transplantation. Am J Transplant 2010;10:1247-53.
22. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007;7:1743-52. (Pubitemid 46905427)
23. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007;7:2124-32. (Pubitemid 47247042)
24. Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy versus rituximab-treated non-splenectomy preconditioning regimens. Contrib Nephrol 2009;162:61-74.
25. Bryan CF, Shield CF 3rd, Nelson PW, Pierce GE, Ross G, Luger AM, Warady BA, Helling TS, Aeder MI, Martinez J, Hughes TM, Beck ML, Harrell KM. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation 1998;66:1714-7. (Pubitemid 29034997)
26. Alkhunaizi AM, de Mattos AM, Barry JM, Bennett WM, Norman DJ. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999;67:1319-24. (Pubitemid 29252406)
27. Kobayashi T, Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation 2006;13:136-40.
28. Kumlien G, Wilpert J, Safwenberg J, Tyden G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007;84:S17-9.
29. AuBuchon JP, de Wildt-Eggen J, Dumont LJ. Reducing the variation in performance of antibody titrations. Vox Sang 2008;95:57-65. (Pubitemid 351799409)
30. Lindberg L, Johansson SM, Liu J, Grufman P, Holgersson J. Is there a clinical need for a diagnostic test allowing detection of chain type-specific anti-A and anti-B? Transfusion; 2011;51:494-503.
31. Yurugi K, Kimura S, Ashihara E, Tsuji H, Kawata A, Kamitsuji Y, Hishida R, Takegawa M, Egawa H, Maekawa T. Rapid and accurate measurement of anti-A/B IgG antibody in ABO-unmatched living donor liver transplantation by surface plasmon resonance. Transfus Med 2007;17:97-106. (Pubitemid 46558252)
32. Sundback M, Grufman P, Teller J, Westphal F, Korchagina E, Bovin N, Holgersson J. Quantification of blood group A and B antibodies by flow cytometry using beads carrying A or B trisaccharides. Transplantation 2007;84:S24-6.
33. Cohney SJ, Hogan C, Haeusler M, Neander E, Fairweather H. Variability of anti-blood group titers accordng to methodology and clinical relevance in ABO-incompatible renal transplantation. Am J Transplant 2007;7:157.
34. Shirey RS, Cai W, Montgomery RA, Chhibber V, Ness PM, King KE. Streamlining ABO antibody titrations for monitoring ABO-incompatible kidney transplants. Transfusion 2010;50:631-4.
35. Roback JD, Combs MR, Grossman BJ, Hillyer CD. Technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008.
36. Klein HG, Mollison PL, Anstee DJ, Mollison PL. Mollison's blood transfusion in clinical medicine. 11th ed. Malden (MA); Oxford: Blackwell Pub.; 2005.